Key points
- Pharmacovigilance systems must operate a structured regulatory intelligence framework.
- Regulatory intelligence must continuously identify and monitor global and local regulatory changes.
- Identified regulatory changes must be assessed for impact on the PV system.
- Impact assessments must drive decisions and defined actions to ensure compliance.
- Regulatory changes must be implemented, tracked, and governed through controlled processes.
- Inspection-ready evidence must demonstrate a complete and continuous regulatory intelligence lifecycle.
What inspectors expect
Each point below should be supported by controlled documents and traceable records.
- Regulatory changes must be continuously monitored.
- All relevant regulatory updates must be assessed for impact.
- Regulatory intelligence must drive defined actions.
- Implementation must be tracked and completed.
- The PV system must remain compliant with current regulations.
Summary
Inspectors assess whether pharmacovigilance systems operate a structured regulatory intelligence framework. They review how regulatory changes are identified, assessed, implemented, tracked, and governed to ensure continuous compliance across global and local requirements.
Common questions
These are the questions this page is designed to answer directly.
- What is regulatory intelligence in pharmacovigilance?
- What do inspectors check for regulatory intelligence?
- How do companies monitor regulatory changes in PV?
- What is a regulatory intelligence framework?
- How are regulatory updates managed in pharmacovigilance?
- How do regulators expect companies to track regulatory changes?
- What is regulatory intelligence process in PV?
- How do you stay compliant with changing PV regulations?
- What is a regulatory intelligence system?
- How do you implement regulatory changes in pharmacovigilance?
Evidence objects inspectors expect
Regulatory Intelligence SOP
- Defined regulatory intelligence lifecycle
- Roles and responsibilities for monitoring and assessment
- Processes for identifying and evaluating regulatory changes
- Integration with PV quality system
Regulatory Intelligence Tracker
- Central log of regulatory changes
- Tracking of identification, assessment, and action status
- Assignment of owners and deadlines
- Status updates from identification to completion
Impact Assessment Documentation
- Structured evaluation of regulatory changes
- Gap analysis against current PV processes
- Risk and impact classification
- Defined action plans and implementation decisions
Implementation and Action Records
- Defined actions to address regulatory changes
- Evidence of SOP updates and system changes
- Training triggered by regulatory updates
- Completion of required compliance actions
Governance and Oversight Evidence
- Monthly regulatory intelligence meetings
- Documented decisions and action tracking
- Cross-functional participation (PV, RA, QA)
- Management oversight of regulatory changes
Continuous Monitoring and Sources
- Monitoring of global regulatory authorities
- Local affiliate regulatory updates
- Defined monitoring frequency and responsibilities
- Evidence of routine source review
Regulatory Basis (Primary Sources)
- GVP Module I – requirement for PV system compliance and oversight
- GVP Module VI – requirements for safety data management aligned with regulations
- ICH E2E – pharmacovigilance planning and anticipation of regulatory requirements
- MHRA GPvP guidance – expectations for monitoring regulatory changes
- FDA pharmacovigilance guidance – requirement to remain compliant with evolving regulations
Typical Inspection Questions (What Inspectors Ask)
- How do you stay up to date with regulatory changes?
- Show me your regulatory intelligence tracker.
- How do you assess the impact of new regulations?
- How do you ensure changes are implemented?
- How is regulatory intelligence governed in your organisation?
Failure patterns
Regulatory changes are not systematically monitored.
Regulatory intelligence is informal or undocumented.
Impact of regulatory changes is not assessed.
Actions are not defined or tracked.
Regulatory changes are identified but not implemented.
What good looks like
- A structured and documented regulatory intelligence framework.
- Continuous monitoring of global and local regulatory sources.
- Defined impact assessment and decision-making process.
- Tracked implementation of regulatory changes.
- Governance ensuring regulatory compliance is maintained.
Operationalisation
- Define a regulatory intelligence process within PV SOPs.
- Monitor regulatory sources continuously.
- Log regulatory changes in a central tracker.
- Perform structured impact assessments.
- Define and implement required actions.
- Review regulatory intelligence through governance processes.
Need regulatory documentation today?
Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.
Related pre-built documentation inside the app
FAQ
What is regulatory intelligence in pharmacovigilance?
Regulatory intelligence is the process of monitoring, assessing, and implementing regulatory changes to ensure ongoing compliance with pharmacovigilance requirements.
How do companies stay compliant with changing PV regulations?
Companies use structured regulatory intelligence processes to monitor updates, assess impact, and implement required changes within their PV systems.
Do inspectors review regulatory intelligence processes?
Yes. Inspectors assess whether companies have a structured and effective process for identifying and implementing regulatory changes.
What is a regulatory intelligence tracker?
A regulatory intelligence tracker is a central log used to record regulatory changes, track their assessment, and monitor implementation actions.
How are regulatory changes implemented in pharmacovigilance?
Changes are implemented through defined actions such as SOP updates, system changes, training, and governance oversight.
Why is regulatory intelligence important?
Regulatory intelligence ensures that pharmacovigilance systems remain compliant with evolving global and local requirements.
Sources
Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.
European Medicines Agency (EMA)
- Guideline on good pharmacovigilance practices (GVP) – Module IView source
- Guideline on good pharmacovigilance practices (GVP) – Module VIView source
FDA
- FDA Postmarketing Safety ReportingView source
ICH
- ICH E2E Pharmacovigilance PlanningView source
MHRA
- Good Pharmacovigilance Practice (GPvP)View source